We use our molecular platform to generate cutting-edge therapeutics based on synthetic miRNA mimic designs, adaptable to virtually any miRNA molecule.
We have engineered a revolutionary new biodegradable polymer for safe and effective therapeutic delivery of nucleic acids, called Nano-in
Nano-in tecnology can deliver different synthetic miRNA mimics to cancer cells, restoring levels of downregulated miRNAs with high efficacy and low toxicity. Nano-in + miR-198 mimic is headed to the clinic as the first of Speratum’s novel class of targeted, molecular therapies against the deadliest cancers.
